This company listing is no longer active
Medica Group Future Growth
Future criteria checks 3/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Medica Group.
Key information
19.6%
Earnings growth rate
19.58%
EPS growth rate
| Healthcare earnings growth | 19.2% |
| Revenue growth rate | 9.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 25 Apr 2023 |
Recent future growth updates
Recent updates
Medica Group (LON:MGP) Will Pay A Larger Dividend Than Last Year At £0.0188
Jun 04
Is Medica Group Plc (LON:MGP) Potentially Undervalued?
Apr 25Medica Group's (LON:MGP) Upcoming Dividend Will Be Larger Than Last Year's
Apr 06Investors Could Be Concerned With Medica Group's (LON:MGP) Returns On Capital
Jan 18Medica Group (LON:MGP) Is Increasing Its Dividend To £0.0093
Sep 30Medica Group's (LON:MGP) Shareholders Will Receive A Bigger Dividend Than Last Year
May 29Medica Group's (LON:MGP) Upcoming Dividend Will Be Larger Than Last Year's
Apr 07Medica Group's (LON:MGP) Upcoming Dividend Will Be Larger Than Last Year's
Oct 06Is It Too Late To Consider Buying Medica Group Plc (LON:MGP)?
Jul 27Medica Group Plc Just Missed Earnings - But Analysts Have Updated Their Models
May 13Why Medica Group Plc (LON:MGP) Could Be Worth Watching
Mar 09Has Medica Group (LON:MGP) Got What It Takes To Become A Multi-Bagger?
Feb 22How Much Did Medica Group's(LON:MGP) Shareholders Earn From Share Price Movements Over The Last Three Years?
Feb 08Does Medica Group's (LON:MGP) Statutory Profit Adequately Reflect Its Underlying Profit?
Jan 12
Medica Group Plc's (LON:MGP) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Dec 30An Intrinsic Calculation For Medica Group Plc (LON:MGP) Suggests It's 38% Undervalued
Dec 17Trade Alert: The Medical Director Of Medica Group Plc (LON:MGP), Stephen Davies, Has Sold Some Shares Recently
Dec 05Should You Think About Buying Medica Group Plc (LON:MGP) Now?
Dec 03We're Watching These Trends At Medica Group (LON:MGP)
Nov 21Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 103 | 14 | 16 | 18 | 3 |
| 12/31/2024 | 95 | 12 | 13 | 16 | 5 |
| 12/31/2023 | 86 | 10 | 11 | 14 | 5 |
| 12/31/2022 | 77 | 7 | 6 | 9 | N/A |
| 9/30/2022 | 74 | 7 | 8 | 10 | N/A |
| 6/30/2022 | 71 | 7 | 10 | 12 | N/A |
| 3/31/2022 | 67 | 6 | 9 | 11 | N/A |
| 12/31/2021 | 62 | 5 | 8 | 10 | N/A |
| 9/30/2021 | 54 | 4 | 5 | 7 | N/A |
| 6/30/2021 | 46 | 2 | 3 | 5 | N/A |
| 3/31/2021 | 42 | 2 | 5 | 7 | N/A |
| 12/31/2020 | 37 | 1 | 7 | 9 | N/A |
| 9/30/2020 | 39 | 3 | 8 | 10 | N/A |
| 6/30/2020 | 42 | 5 | 10 | 12 | N/A |
| 3/31/2020 | 44 | 6 | 8 | 11 | N/A |
| 12/31/2019 | 47 | 8 | 7 | 10 | N/A |
| 9/30/2019 | 44 | 8 | 6 | 9 | N/A |
| 6/30/2019 | 42 | 8 | 5 | 8 | N/A |
| 3/31/2019 | 41 | 8 | 6 | 9 | N/A |
| 12/31/2018 | 39 | 7 | 8 | 10 | N/A |
| 9/30/2018 | 38 | 7 | 8 | 10 | N/A |
| 6/30/2018 | 37 | 7 | 8 | 10 | N/A |
| 3/31/2018 | 35 | 6 | 6 | 8 | N/A |
| 12/31/2017 | 34 | 4 | 4 | 6 | N/A |
| 9/30/2017 | 32 | 3 | 4 | 5 | N/A |
| 6/30/2017 | 31 | 2 | 4 | 5 | N/A |
| 3/31/2017 | 30 | 3 | 5 | 6 | N/A |
| 12/31/2016 | 29 | 3 | 6 | 7 | N/A |
| 9/30/2016 | 27 | 3 | N/A | 7 | N/A |
| 12/31/2015 | 22 | 2 | N/A | 6 | N/A |
| 12/31/2014 | 18 | 0 | N/A | 5 | N/A |
| 12/31/2013 | 14 | -1 | N/A | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MGP's forecast earnings growth (19.6% per year) is above the savings rate (1.2%).
Earnings vs Market: MGP's earnings (19.6% per year) are forecast to grow faster than the UK market (8.7% per year).
High Growth Earnings: MGP's earnings are forecast to grow, but not significantly.
Revenue vs Market: MGP's revenue (9.8% per year) is forecast to grow faster than the UK market (4.5% per year).
High Growth Revenue: MGP's revenue (9.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MGP's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/07/08 17:55 |
| End of Day Share Price | 2023/07/06 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medica Group Plc is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jakob Berry | Berenberg |
| Charles Weston | Berenberg |
| Andrew Whitney | Investec Bank plc (UK) |